Johnson & Johnson (JNJ) Tops Q4 EPS by 2c, FY Guidance Tops Views

Johnson & Johnson (NYSE: JNJ) reported Q4 EPS of $1.74, $0.02 better than the analyst estimate of $1.72. Revenue for the quarter came in at $20.2 billion versus the consensus estimate of $20.08 billion.

GUIDANCE:

Johnson & Johnson sees FY2018 EPS of $8.00-$8.20, versus the consensus of $7.87. Johnson & Johnson sees FY2018 revenue of $80.6-81.4 billion, versus the consensus of $80.7 billion.

For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• InspireMD (NSPR) Tops Q2 EPS by 1c
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance